Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
about
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosisEthics of mandatory vaccination for healthcare workersAutoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort studyFrequently asked questions on seven rare adverse events following immunization.Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.Influenza vaccination in India: position paper of Indian Academy of Pediatrics, 2013.Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in EuropePandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in GermanyResponding to vaccine safety signals during pandemic influenza: a modeling study.Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital diDeaths following vaccination: What does the evidence show?Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea.Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States.In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.Vaccine Safety Resources for NursesOntology-based Vaccine and Drug Adverse Event Representation and Theory-guided Systematic Causal Network Analysis toward Integrative Pharmacovigilance ResearchInfectious and noninfectious triggers in Guillain-Barré syndrome.Emerging infections of the central nervous system.Perspectives on the future of postmarket vaccine safety surveillance and evaluation.Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.Overall conceptual framework for studying the genetics of autoimmune diseases following vaccination: a regulatory perspective.A case of myositis of the deltoid muscle of the upper arm developing 1 week after influenza vaccination: case report.Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an updateDid the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barré syndrome?Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.Influenza vaccines: Evaluation of the safety profile.Influenza Vaccine and Autoimmune Diseases
P2860
Q22251013-514E0DA8-3438-478E-8AC8-4E211077E7EAQ26828904-A6572C8B-EB9F-4D73-8890-6DEFC5247B1AQ28300023-7BF15A08-2EC8-4827-8812-ABAD8DD9CFB3Q30234430-7251FBDA-7802-4DD3-8B8A-E3ECC7141076Q30351998-E9AC6796-EA97-44F5-8607-0210A61C2711Q30352329-5459221F-422A-4A35-9DA5-4D94EB43B8D0Q30354181-3AF09C7F-825F-46E5-B0F2-2CF5E794547AQ30357675-6E871B9A-12B4-408D-A24D-DA97FF8D0337Q30359657-637D3CA4-D456-4CA1-9294-54543C25DF45Q30362413-62D62007-6021-40C6-AF3A-6E818285A323Q30370076-949BE800-FCB6-4D63-B82D-77B0040C2F77Q30374961-3929BB78-C20F-4127-9900-D5053DF06D33Q30388367-50403E45-F7BC-4324-9779-F3872B7D99DEQ33165769-C097DB3E-AE30-4566-816C-620AD8C9164BQ33770375-73FA90DC-97EF-4224-B20C-2708BD19C45CQ34271547-BB929B1B-50AF-480E-BE98-B048CA9BE240Q34700616-666D60D5-F80B-4C52-A997-037A1B11E106Q36142449-8C58295E-D92D-42CD-AB16-E29BCF92BF2EQ37118671-0D78A1F7-DA3F-4D15-82AF-3E1153BE9EBEQ38125242-125BF865-2EA2-4535-B0C6-B6C440AC5903Q38153635-36C7DF21-8693-43A8-B0B5-42456E9128F3Q38194216-1BBF88EB-F64D-419A-9B79-44B7BD2E7B32Q38587703-3C15615F-B931-4D96-B97D-50E5EE2F90F7Q41156699-B8532C97-E8F6-46C9-A5E6-F360DEC1CADBQ41844412-396DF314-A024-491A-B981-54BD1EFE7EA5Q42181872-CD4B4D9C-185A-4994-832A-6554730B13BAQ43700573-50970D97-6779-4087-AB45-F7D7CBE8475CQ45162452-CE44692A-63C5-4FB7-A9E8-7ACBDD2F666CQ49345779-975AC793-32E6-4A38-AFED-5DC9EBA3BA03Q58051969-BD5E177C-24CA-4CAE-AE9F-E3442CD489EE
P2860
Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Association between Guillain-B ...... s in the USA: a meta-analysis.
@ast
Association between Guillain-B ...... s in the USA: a meta-analysis.
@en
type
label
Association between Guillain-B ...... s in the USA: a meta-analysis.
@ast
Association between Guillain-B ...... s in the USA: a meta-analysis.
@en
prefLabel
Association between Guillain-B ...... s in the USA: a meta-analysis.
@ast
Association between Guillain-B ...... s in the USA: a meta-analysis.
@en
P2093
P50
P921
P1433
P1476
Association between Guillain-B ...... s in the USA: a meta-analysis.
@en
P2093
Bruce Gellin
Claudia Vellozzi
Dale R Burwen
Francesca Cunningham
Grace M Lee
H1N1 GBS Meta-Analysis Working Group
Michael Proschan
Patrick Garman
Paul Gargiullo
W Katherine Yih
P304
P356
10.1016/S0140-6736(12)62189-8
P407
P577
2013-03-13T00:00:00Z